David Dantzker

Director/Board Member chez SURMODICS, INC. Fortune : 1 M $ au 31/03/2024

Profil

David R.
Dantzker founded Oligomerix, Inc. in 2006, where he is working as Director from 2011.
Dr. Dantzker also founded The Feinstein Institutes for Medical Research.
Dr. Dantzker also currently works at Origin Life Sciences, Inc., as Deputy Chairman & Chief Medical Officer from 2012, Surmodics, Inc., as Independent Director from 2011, ShiftWise, Inc., as Director, Shire Regenerative Medicine, Inc., as Director, Wheatley Partners LP, as Partner, Wheatley Medtech Partners LP, as Partner from 2001, and Wheatley Partners, as Partner from 2001.
Dr. Dantzker also formerly worked at Redox Pharmaceutical Corp., as Chief Executive Officer from 2000 to 2001, Long Island Jewish Medical Center, as President & Chief Executive Officer in 1997, American Board of Internal Medicine, as Chairman, Versamed Medical Systems LLC, as Chairman, CNS, Inc. (Delaware), as Director, Datascope Corp., as Director from 2008 to 2009, Agilix Corp., as Director, Valera Pharmaceuticals, Inc., as Director from 2003 to 2007, Comprehensive NeuroScience, Inc., as Director, Physicians for Human Rights, as Treasurer & Director, Woodbrook Group Holdings, Inc., as Director, Respiri Ltd., as Independent Non-Executive Director from 2012 to 2014, NovaRay Medical, Inc., as Director, VisionSense Ltd., as Director, Care Management Technologies, Inc., as Director, Comprehensive Clinical Development, Inc., as Director, the University of Michigan, as Professor-Medicine, Northwell Health, Inc., as President in 2000, Albert Einstein College of Medicine, Inc., as Professor-Medicine, and the University of Texas at Austin, as Professor-Medicine.
Dr. Dantzker received his undergraduate degree from New York University and doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SURMODICS, INC. 0,27%	08/02/2024	39 124 ( 0,27% )	1 M $	31/03/2024

Postes actifs de David Dantzker

Sociétés	Poste	Début
SURMODICS, INC.	Director/Board Member	05/01/2011
ShiftWise, Inc.	Director/Board Member	-
Wheatley Medtech Partners LP	Corporate Officer/Principal	01/01/2001
Wheatley Partners LP	Corporate Officer/Principal	-
Origin Life Sciences, Inc.	Chief Tech/Sci/R&D Officer	01/01/2012
Oligomerix, Inc.	Founder	01/01/2006
Wheatley Partners	Private Equity Investor	01/01/2001
Shire Regenerative Medicine, Inc.	Director/Board Member	-

Anciens postes connus de David Dantzker

Sociétés	Poste	Fin
RESPIRI LIMITED	Director/Board Member	05/02/2014
░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

Formation de David Dantzker

New York University	Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences	Doctorate Degree